All timelines
CompaniesUnited States

CVS Health to split off its pharmacy business in a breakup planned for 2028

4 articles from 4 sources
First reported on Wednesday 4 November 2026 at 01:52 EST by Forbes·Latest article on Wednesday 4 November 2026 at 09:22 EST

Summary

CVS Health intends to split off its pharmacies into a new company in a breakup planned for 2028, while keeping together its businesses in insurance and pharmacy benefits, The NY Times reported on Wednesday 4 November, Forbes writing that CVS Health will split into two companies, putting the more than 9,000 drugstores under one business and its Aetna health insurance and pharmacy benefit operations into another. The move would reverse the company's $78 billion acquisition of Aetna and dismantle the vertically integrated healthcare conglomerate it created in 2018, CNBC reported, and The Philadelphia Inquirer wrote that CVS Health has been under mounting scrutiny from lawmakers, regulators and others who say the company, along with its peers UnitedHealth Group and Cigna, has grown too dominant.

Latest: CVS Health intends to split off its pharmacies into a new company in a breakup planned for 2028, keeping together its businesses in insurance and pharmacy benefits, The NY Times reported, CNBC writing that the move would reverse the company's $78 billion acquisition of Aetna and The Philadelphia Inquirer that CVS Health has been under mounting scrutiny from lawmakers, regulators and others.

Written automatically by an AI from the articles' headlines and descriptions. It can contain errors: follow the links to read the articles.

How it unfolded

  1. Wednesday 4 November

    CVS Health intends to split off its pharmacies into a new company in a breakup planned for 2028, keeping together its businesses in insurance and pharmacy benefits, The NY Times reported, CNBC writing that the move would reverse the company's $78 billion acquisition of Aetna and The Philadelphia Inquirer that CVS Health has been under mounting scrutiny from lawmakers, regulators and others.